4.7 Article

Glucocerebrosidase mutations are an important risk factor for Lewy body disorders

Journal

NEUROLOGY
Volume 67, Issue 5, Pages 908-910

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1212/01.wnl.0000230215.41296.18

Keywords

-

Funding

  1. Intramural NIH HHS Funding Source: Medline
  2. NIA NIH HHS [AG09215] Funding Source: Medline

Ask authors/readers for more resources

The synucleinopathies are neurodegenerative disorders defined by inclusions composed of aberrantly fibrillized alpha-synuclein, but factors contributing to this process remain largely unknown. The authors examined the glucocerebrosidase gene in 75 autopsy specimens with different synucleinopathies and identified mutations in 23% of cases of dementia with Lewy bodies, expanding on previous findings in subjects with Parkinson disease. Mutations in this lysosomal protein may interfere with the clearance or promote aggregation of alpha-synuclein.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available